Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-05

Clinical Trial Update: Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating amitriptyline or pregabalin for neuropathic pain in incurable cancer. The status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)
  • amitriptyline (amitriptyline)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Cancer, Neuralgia | Phase 3 | Status: UNKNOWN